ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer

NCT05824559 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
23
Enrollment
INDUSTRY
Sponsor class

Stopped Company decision to wind down operations, close all clinical programs and evaluate strategic options

Conditions

Interventions

Sponsor

MEI Pharma, Inc.